CORC  > 河北省人民医院
Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study.
Wanzhen Yao; Changzheng Wang; Nanshan Zhong; Xiaowen Han; Changgui Wu; Xixin Yan; Ping Chen; Wei Yang; Michelle Henley; Benjamin Kramer
刊名Respirology
2014
卷号Vol.19 No.2页码:231-238
关键词Chinese chronic obstructive pulmonary disease efficacy indacaterol safety
ISSN号1323-7799
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2004051
专题河北省人民医院
作者单位1.The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
2.People's Hospital of Hebei Province, Shi Jia Zhuang, China
3.Xingiao Hospital, Third Military Medical University, Chongqing, China
4.Department of Respiratory Medicine, Xijing Hospital, Xi'an, China
5.The Second Hospital of Hebei Medical University, Shi Jia Zhuang, China
6.Guangzhou Institute of Respiratory Disease, Guangzhou, China
7.Peking University Third Hospital, Beijing, China
8.Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
推荐引用方式
GB/T 7714
Wanzhen Yao,Changzheng Wang,Nanshan Zhong,et al. Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study.[J]. Respirology,2014,Vol.19 No.2:231-238.
APA Wanzhen Yao.,Changzheng Wang.,Nanshan Zhong.,Xiaowen Han.,Changgui Wu.,...&Benjamin Kramer.(2014).Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study..Respirology,Vol.19 No.2,231-238.
MLA Wanzhen Yao,et al."Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study.".Respirology Vol.19 No.2(2014):231-238.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace